KAZIA THERAPEUTICS LTD - SCHEDULE 13G/A Filing

Jorey Chernett, a significant shareholder, has updated their filing for KAZIA THERAPEUTICS LTD. As of March 24, 2026, Chernett beneficially owns 1,588,129 American Depositary Shares (ADS), representing 13.90% of the company's outstanding ADSs. This filing, designated as SCHEDULE 13G/A, indicates an amendment to a previous filing. The total number of outstanding ADSs is based on information from KAZIA THERAPEUTICS LTD's Form F-3 registration statement. Chernett certifies that these shares were not acquired or held with the purpose or effect of changing or influencing the control of the issuer, nor in connection with any such transaction, except for activities related to nominations under Rule 240.14a-11. The filing date for this amendment is March 31, 2026, with the event date being March 24, 2026. Chernett's principal business address is in Bloomfield Hills, MI, USA.